Skip to main content
Home / News / Certara Appoints New Head of Biometrics, Data Science, and Access 

Certara Appoints New Head of Biometrics, Data Science, and Access 

RADNOR, PA. – January 10, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Tiffany Woodworth as Head of Biometrics, Data Science and Access. This strategic appointment underlines Certara’s commitment to advancing its capabilities in modeling and simulation, regulatory science, and market access. In this role, she will lead the biostatistics, statistical programming, PK/PD programming, advanced analytics, data science, market access and real-world evidence teams at Certara. 

Ms. Woodworth has 19 years of leadership experience in the Life Sciences industry, successfully steering teams through strategic growth and operational excellence. She joins Certara from Panalgo, where she served as President and General Manager, delivering significant revenue growth and profitability. She received her MPH at Boston University School of Public Health and her MBA from the Fox School of Business at Temple University. 

“Certara’s mission to accelerate medicines to patients through innovation aligns perfectly with my own career principles, as does the talented team of colleagues I’ll be working alongside,” said Tiffany Woodworth. “I’m excited to lead the Biometrics, Data Science and Access team and further expand our ability to deliver cutting-edge solutions that improve global healthcare.”  

Patrick Smith, President, Certara Drug Development Solutions, commented, “Tiffany’s leadership and proven track record in biometrics and data science make her a valuable asset to our team. We are enthusiastic about the role she’ll play in helping us deliver solutions that help our clients develop safer, more effective medicines, faster.”  

About Certara  

Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.   

Certara Contact:  
Sheila Rocchio  
sheila.rocchio@certara.com   

Media Contact:  
Alyssa Horowitz  
certara@pancomm.com